However, according to the IHC results in the abovementioned studies, FGL1 is expressed on the surface of breast cancer cells, or in the cytoplasm of NSCLC cells, whereas LAG3 is expressed on the surface of lymphocytes. This evidence concerns the gene LAG3 and breast carcinoma.